Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial

Germano Melissano; Andrea Kahlberg; Luca Bertoglio; Roberto Chiesa

doi:10.1583/10-3340.1

Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial

Germano Melissano, Andrea Kahlberg, Luca Bertoglio, Roberto Chiesa

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To compare the midterm results of endovascular treatment of thoracic aortic aneurysms and ulcers in patients who received either a 1-component or 2-component Zenith TX2 stent-graft. Methods: Data were gathered from a prospectively maintained registry for the Zenith TX2 pivotal trial. Among 158 patients who underwent thoracic endovascular aortic repair (TEVAR) between March 2004 and July 2006, 64 received a 1-component stent-graft (group 1) and 94 patients a 2-component device (group 2). Results: In group 2, there were more men (79% vs. 63%; p=0.03), and the patients had more diagnosed (p

Original language	English
Pages (from-to)	338-349
Number of pages	12
Journal	Journal of Endovascular Therapy
Volume	18
Issue number	3
DOIs	https://doi.org/10.1583/10-3340.1
Publication status	Published - Jun 2011

Keywords

Modular device
Penetrating aortic ulcer
Stent-graft
Thoracic aortic aneurysm
Thoracic endovascular aortic repair

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Access to Document

10.1583/10-3340.1

Fingerprint Dive into the research topics of 'Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial'. Together they form a unique fingerprint.

Cite this

Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts : Analysis of 2-year data from the TX2 pivotal trial. / Melissano, Germano ; Kahlberg, Andrea; Bertoglio, Luca; Chiesa, Roberto.

In: Journal of Endovascular Therapy, Vol. 18, No. 3, 06.2011, p. 338-349.

Research output: Contribution to journal › Article › peer-review

@article{3e07df0423a64d8abcc5b191354a9e92,

title = "Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial",

abstract = "Purpose: To compare the midterm results of endovascular treatment of thoracic aortic aneurysms and ulcers in patients who received either a 1-component or 2-component Zenith TX2 stent-graft. Methods: Data were gathered from a prospectively maintained registry for the Zenith TX2 pivotal trial. Among 158 patients who underwent thoracic endovascular aortic repair (TEVAR) between March 2004 and July 2006, 64 received a 1-component stent-graft (group 1) and 94 patients a 2-component device (group 2). Results: In group 2, there were more men (79% vs. 63%; p=0.03), and the patients had more diagnosed (p",

keywords = "Modular device, Penetrating aortic ulcer, Stent-graft, Thoracic aortic aneurysm, Thoracic endovascular aortic repair",

author = "Germano Melissano and Andrea Kahlberg and Luca Bertoglio and Roberto Chiesa",

year = "2011",

month = jun,

doi = "10.1583/10-3340.1",

language = "English",

volume = "18",

pages = "338--349",

journal = "Journal of Endovascular Therapy",

issn = "1526-6028",

publisher = "International Society of Endovascular Specialists",

number = "3",

}

TY - JOUR

T1 - Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts

T2 - Analysis of 2-year data from the TX2 pivotal trial

AU - Melissano, Germano

AU - Kahlberg, Andrea

AU - Bertoglio, Luca

AU - Chiesa, Roberto

PY - 2011/6

Y1 - 2011/6

N2 - Purpose: To compare the midterm results of endovascular treatment of thoracic aortic aneurysms and ulcers in patients who received either a 1-component or 2-component Zenith TX2 stent-graft. Methods: Data were gathered from a prospectively maintained registry for the Zenith TX2 pivotal trial. Among 158 patients who underwent thoracic endovascular aortic repair (TEVAR) between March 2004 and July 2006, 64 received a 1-component stent-graft (group 1) and 94 patients a 2-component device (group 2). Results: In group 2, there were more men (79% vs. 63%; p=0.03), and the patients had more diagnosed (p

AB - Purpose: To compare the midterm results of endovascular treatment of thoracic aortic aneurysms and ulcers in patients who received either a 1-component or 2-component Zenith TX2 stent-graft. Methods: Data were gathered from a prospectively maintained registry for the Zenith TX2 pivotal trial. Among 158 patients who underwent thoracic endovascular aortic repair (TEVAR) between March 2004 and July 2006, 64 received a 1-component stent-graft (group 1) and 94 patients a 2-component device (group 2). Results: In group 2, there were more men (79% vs. 63%; p=0.03), and the patients had more diagnosed (p

KW - Modular device

KW - Penetrating aortic ulcer

KW - Stent-graft

KW - Thoracic aortic aneurysm

KW - Thoracic endovascular aortic repair

UR - http://www.scopus.com/inward/record.url?scp=79959296159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959296159&partnerID=8YFLogxK

U2 - 10.1583/10-3340.1

DO - 10.1583/10-3340.1

M3 - Article

C2 - 21679072

AN - SCOPUS:79959296159

VL - 18

SP - 338

EP - 349

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 3

ER -

Endovascular exclusion of thoracic aortic aneurysms with the 1- and 2-component Zenith TX2 TAA endovascular grafts: Analysis of 2-year data from the TX2 pivotal trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this